Sign in with Google
|
USD 2.97
Price
-0.24
(-7.48%)
Day Change
|
|
|---|
PBYI, the overall quality is good (Quality = 77) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.
In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
61% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 4 |
| Magic Formula Rank by ROA |
521
|
| Magic Formula Rank by ROE |
521
|
| Magic Formula Rank by ROIC |
297
|
| Price | 2.97 |
| PBV / Sector |
2.05 / 1.31
|
| Earning Per Share | 0.19 |
| PE / Sector |
15.63 / 18.08
|
| PEG or PE/Growth / Sector |
0.03 / 6.13
GREAT
|
| Average 1M Daily Value |
1.28 M
GREAT
|
| Average 1W Daily Value |
3.01 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2024-11-14 19:39:05 |
| Symbol | PBYI |
| Name | PUMA BIOTECHNOLOGY INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 49.05 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 145.79 / 4,296.93 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
UTHR 
